U.S. Electrical Stock News

loanDepot stock barely flinched after earnings, slipping just 0.9% to close near US$1, even though the headline story was a sharply smaller quarterly loss. Net loss narrowed to US$4.5m in Q2 on roughly US$295m of revenue, a marked improvement from the heavy red ink investors saw at the start of the year. The short term tape still looks bruised, with the share price down double digits over the past month. Yet the earnings call focused on a longer game, with management emphasizing rising gain...

Mercury General stock added 2.8% today to US$109.61, even though the real story sits in the insurer’s profit engine rather than the headline price pop. The key signal is margin. Trailing net profit margin sits at 13.7% compared with 5.1% a year earlier, and earnings over the past year are reported to be close to triple last year’s level. Investors cheering the move are reacting to a company that, on recent numbers, is earning more on each premium dollar while still trading on a single digit...

Alphatec Holdings just gave shareholders a jolt. The stock closed at US$9.57, down about 7.5% on the day, even though the headline from Q2 was clear. Revenue reached about US$214 million and adjusted earnings before interest, tax, depreciation and amortisation climbed to about US$36 million. Short term traders focused on the red on the screen. Longer term investors will likely be more interested in what this quarter says about Alphatec Holdings’ push toward higher margins, sustained double...

Select Water Solutions stock came into today on a strong run, with double digit gains over the past week and month, only to meet fresh Q2 numbers that put the focus squarely on earnings power. The headline is simple. Profit and revenue both sit solidly in the black, with Q2 net income of US$21.0 million on US$395.8 million of revenue, and basic EPS of roughly US$0.15. The bigger story for long term investors is the valuation strain. Select Water Solutions trades on a P/E that is far above...

Wynn Resorts stock jumped 3.6% to about US$101 in regular trading after its Q2 report, a sharp move for a company whose 90 day return has been under pressure. The market is reacting to one thing above all else: profitability is firming even as revenue holds near US$1.9b and net income from ongoing operations reaches roughly US$140m. That short term pop sits against a longer horizon where earnings have been growing over multiple years but face clear balance sheet risks. The headline today is...

The market marked Celanese down almost 5% today. Yet the headline from this earnings release is not collapse but compression. The stock sold off as investors fixated on the company’s still-weak trailing profit picture, even as quarterly earnings per share climbed back above US$1 and net income returned to a positive US$127m in Q2. For a chemicals producer that has been wrestling with losses and interest burdens, that profit squeeze and the struggle to cover financing costs remain the...

Healthy growth is hard to find when global data is so mixed, with some regions picking up speed and others cooling. A focused screener that looks for companies where analysts expect strong earnings growth over the next 3 years, while also checking that balance sheets are in acceptable shape, can help you cut through the noise. The Healthy high growth potential screener does exactly that. In this article you will see 3 stocks from this universe that stand out on growth quality and financial...

PACS Group stock closed up 1.9% at US$45.64 after its latest report, a measured move for a company that just reported another quarter of stronger earnings. Net income reached US$76.4 million on US$1.43b of revenue, resulting in a trailing net margin of 4.8% that now sits well above last year’s level. The short-term reaction is modest. The bigger story is that investors now have to weigh that improving profitability against a P/E of 26.8x, along with multi-year earnings growth forecasts that...

Lattice Semiconductor shareholders woke up to a sentiment shock. The stock dropped about 7% to US$128.31 on the first trading day after earnings, even as the company posted record Q2 revenue of US$201.1m and strong earnings per share of US$0.14 on a basic basis and US$0.53 on a non generally accepted accounting principles basis. The market is treating the print as a problem. The numbers read more like a stress test in a stock that was already priced for perfection. Impressed by Lattice...

Interparfums stock gave up 4% today, which looks more like a mood swing than a verdict on the business. The fragrance group just posted Q2 revenue of US$341.0m with basic earnings per share of US$0.95. These numbers sit in the context of a trailing twelve month basic earnings per share figure of US$5.23. The key issue is margin pressure. Operating profitability for the first half of 2026 has softened, even as tariff refunds and strong brands help cushion the impact. That is what today’s price...

Bio-Rad Laboratories stock jumped about 4.5% in regular trading, which indicates that traders responded positively to the latest results. The bigger story is less about a one-day move and more about whether this quarter marks a cleaner earnings run rate after a very choppy year. Q2 revenue was US$651 million and non-GAAP earnings per share were US$2.62, roughly in line with the same period last year. For long-term holders, the key question is how this steadier quarter fits with modest growth...

TransDigm Group’s stock slipped about 1.6% today, yet the quarterly story investors just saw was about profit power holding firm despite a heavy balance sheet. Q3 revenue reached US$2.741b with net income of US$539m, keeping basic earnings per share near double digits at US$9.39. Those profits sit on top of roughly US$33.7b of gross debt and interest coverage of about 3x, which keeps leverage in focus. For a stock that had cooled a bit over the past month, this earnings report highlights how...

Adaptive Biotechnologies stock barely budged after earnings, closing up just 0.2% around US$24.61. That muted move sits awkwardly against a quarter that put its core cancer minimal residual disease diagnostics front and center. Total revenue reached US$71.6m, while the company reported a net loss of US$39.8m that was heavily influenced by debt extinguishment and interest tied to the OrbiMed agreement. The key takeaway for investors is margin and profit pressure alongside a strong MRD growth...

DaVita stock just endured a 17% single day drop, yet the earnings story that triggered it looks far more measured. The company delivered adjusted earnings per share of US$4.02 in the quarter and reaffirmed full year adjusted earnings guidance around US$14.65. For a healthcare services stock that closed yesterday near US$228 and now trades around US$189, this is a sentiment shock focused less on an earnings miss and more on worries about long term margins and debt. Is DaVita suddenly a 48% off...

Entegris stock barely flinched after earnings, up just 0.8% to US$145.75, yet the report itself was anything but muted. The market treated it as just another decent quarter. The numbers pointed to something more important for a high multiple semiconductor supplier. The real story was margin power. Revenue landed at US$883.2m with adjusted gross margin at 47.6%, the strongest level since early 2022, and adjusted EBITDA margin at 28.4%. For a stock trading on a rich trailing P/E of 72.8x, that...

Navigator Holdings came into this print with a stock that had cooled off in the near term and sat roughly flat over the past month, yet the market still knocked the shares down about 4% to US$20.57 on the day. That reaction sits awkwardly against what was just reported. Q2 delivered record net income of US$53.0m and record earnings per share of US$0.86, powered by very strong time charter equivalent rates and utilization across its liquefied gas fleet. The tension for investors now is clear...

RPM International recently reported full-year results for the period ended May 31, 2026, with sales rising to US$7,863.42 million from US$7,372.64 million a year earlier, while net income eased to US$661.39 million from US$688.69 million and diluted EPS from continuing operations softened to US$5.17 from US$5.35. The combination of higher revenue but lower earnings and EPS underlines pressure on profitability, raising questions about cost controls and margin resilience across RPM’s...

US Foods Holding (USFD) has drawn investor attention after its share price closed at $100.49, with the stock showing mixed short term moves alongside stronger results over the past 3 years and 5 years. See our latest analysis for US Foods Holding. The recent 1 day share price gain of 1.46% and softer 7 and 30 day share price returns suggest some near term consolidation, while the 90 day share price return of 15.67% and multi year total shareholder returns above 180% point to momentum that has...

Life Time Group Holdings (LTH) shares reacted to a packed July 30 update, as the company reported higher quarterly and half year sales, raised full year guidance, outlined new club openings, and completed a buyback tranche. See our latest analysis for Life Time Group Holdings. Life Time Group Holdings' latest update comes after a strong run in the stock, with a 30 day share price return of 10.16% and a 90 day share price return of 40.76% contributing to a 3 year total shareholder return of...

Danaher Corporation recently announced that its Board appointed Julie Sawyer Montgomery as President, Chief Executive Officer, and Board member, effective October 1, 2026, with outgoing CEO Rainer Blair remaining as senior advisor until March 31, 2027 to support the leadership transition. Sawyer Montgomery’s elevation to the top role follows her central role in expanding Danaher’s Diagnostics platform from about US$6.0 billion to about US$11.0 billion in revenue since 2017 and roughly...

The latest hiring data shows private sector job creation barely moving, yet healthcare stands out as one of the few pockets of growth. For investors, that mix of slower overall employment and concentrated gains in healthcare and services can reshape where capital feels comfortable. This article looks at how that backdrop, including a 7% jump in pay for job switchers and renewed focus on Federal Reserve policy, lines up with three healthcare stocks exposed to this news. You will see which...

Dynatrace has had a solid run so far in 2026 with the stock up 20.1% year to date, yet its valuation checks are sending mixed signals. A Discounted Cash Flow (DCF) estimate points to upside, while market based multiples look rich and the overall value score is weak. Year to date, Dynatrace has gained 20.1%, which puts more pressure on today’s price to be supported by future cash flows rather than just recent share price momentum. Recent product updates around AI powered observability and...

Phillips 66 stock has delivered a very strong run over the past five years, yet the current valuation checks suggest the shares are not a clear bargain at today’s levels. Over the past 5 years Phillips 66 has returned 228.8%, which puts recent gains front and center for anyone thinking about new money going into the stock. The recent $10b increase in share repurchase authorization can support earnings per share and valuation. However, the company’s high debt and balance sheet constraints may...

Ovintiv (OVV) is back on investors radar after a packed July 23 update that combined second quarter 2026 earnings, revised production guidance, a confirmed dividend and fresh details on its share buyback activity. See our latest analysis for Ovintiv. Despite the busy earnings day on 23 July and confirmation of dividends and buybacks, Ovintiv’s recent trading has been choppy, with the share price down 4.59% on the day and 5.42% over the past week, but up 8.74% over 30 days and showing strong...